Bausch Health Companies, Inc. is recalling 3,600 cartons of Omeprazole and Sodium Bicarbonate For Oral Suspension (40mg/1,680mg) distributed under the Oceanside Pharmaceuticals brand. The medication is being recalled because it was found to be subpotent, meaning it did not meet the required potency specifications during testing. If you have health concerns regarding this medication, contact your healthcare provider or pharmacist.
A subpotent drug contains less of the active ingredient than indicated on the label, which may result in a patient receiving an inadequate dose and failing to properly manage their medical condition. No specific injuries or adverse events were reported in the recall notice.
You have 2 options:
Distributed by Oceanside Pharmaceuticals; This packet contains 40mg of omeprazole and 1,680mg of sodium bicarbonate.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.